Peptide profile · Hormone Support
Abarelix
GnRH Antagonist for Advanced Prostate Cancer Treatment
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
100 mg
Half-life
Approximately 13 days
Bioavailability
~100% (intramuscular depot injection)
Molecular weight
1416.1 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C72H95ClN14O14
Primary benefits
Rapid testosterone suppression without initial flare effect
Effective for advanced and metastatic prostate cancer
Avoids testosterone surge seen with GnRH agonists
Praecis Pharmaceuticals (now NeoTherapeutics)
Amino acid sequence
D-Ala-D-Phe(4-Cl)-D-Ala-Ser-Tyr-D-Asp-Leu-Lys(iPr)-Pro-D-Ala-NH202 · Dosing
How much do I take?
100 mg · day 1, 15, 29, then every 4 weeks
Intramuscular: An injection into a muscle, usually the thigh, shoulder, or buttock.
Bioavailability High — well absorbed into the bloodstream from the muscle.
Best time to take
Administer Abarelix at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Abarelix injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Abarelix should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for reducing testosterone levels in prostate cancer & slowing cancer progression in advanced disease
Best for
Reducing testosterone levels in prostate cancer
Abarelix is particularly well-suited for individuals focused on reducing testosterone levels in prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Slowing cancer progression in advanced disease
Abarelix is particularly well-suited for individuals focused on slowing cancer progression in advanced disease. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Managing hormone-dependent cancer symptoms
Abarelix is particularly well-suited for individuals focused on managing hormone-dependent cancer symptoms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Abarelix with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Intramuscular injection (depot formulation) · Subcutaneous injection
Reconstitution — what you need
Example
Add the recommended volume of bacteriostatic water to the Abarelix vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Abarelix is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Technique
- 01Wash your hands thoroughly with soap and water before handling supplies
- 02Clean the injection site with an alcohol swab and let it air dry completely
- 03Pinch a fold of skin at the chosen injection site
- 04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 05Inject the medication slowly and steadily over 5-10 seconds
- 06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 07Rotate injection sites to prevent tissue irritation or lipodystrophy
- 08Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage · before reconstitution
Store Abarelix in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, Abarelix should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
10 common side effects · 2 serious
Abarelix carries significant safety concerns primarily related to histamine release reactions, which led to its voluntary withdrawal from the U.S. market in 2006. Serious allergic responses including anaphylaxis, flushing, and hypotension have been documented. Long-term use poses substantial risks of bone density loss, cardiovascular effects from hormonal suppression, and metabolic complications including weight gain and altered lipid profiles. Liver enzyme elevations occur in 5-10% of patients. All use requires intensive medical supervision with regular monitoring of testosterone levels, liver function, bone density, and cardiovascular markers.
Abarelix was studied through Phase 3 clinical trials and FDA approval before its market withdrawal. Evidence includes the pivotal studies showing rapid testosterone suppression without initial flare, but also documented cases of serious histamine-mediated reactions. The evidence base is primarily from the 2003-2006 approval period, with limited post-market surveillance data due to its discontinuation. No new human trials have been conducted in recent years, making current safety data approximately 20 years old.
Common side effects · experienced by some users
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Abarelix
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Abarelix should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓Bicalutamide (antiandrogen for added testosterone blocking) — May be used together under medical guidance.
- ✓Supportive hormone replacement therapy (as directed) — May be used together under medical guidance.
- ✓Bone-protective agents for long-term therapy — May be used together under medical guidance.
With medications
- !Other GnRH agonists simultaneously — Use with caution—discuss with your healthcare provider.
- !Certain antiandrogens without medical supervision — Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins — Generally safe to take alongside Abarelix. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs days 1-7
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Abarelix works like a GnRH antagonist, immediately blocking testosterone production in men with prostate cancer. Unlike older treatments that first stimulate hormone release before suppressing it, abarelix goes straight to blocking the hormones, providing rapid control without the initial surge.
Abarelix is a synthetic decapeptide GnRH antagonist with modifications providing competitive blockade at pituitary GnRH receptors. Unlike agonists, abarelix prevents FSH/LH release without initial stimulation, rapidly suppressing testosterone to castration levels within 48 hours.
What to expect
Days 1-7
What you might notice
- •Rapid GnRH receptor blockade begins
- •Testosterone suppression starts without initial surge
What's normal
- •Initial response to Abarelix is beginning at the cellular level
- •Different individuals experience Abarelix's onset at different rates
- •Transient systemic effects from initial Abarelix exposure are common
What's next
- →Maintain consistent Abarelix administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Weeks 2-4
What you might notice
- •Testosterone levels reach castration levels (less than 50 ng/dL)
- •Hormonal effects (hot flashes, decreased libido) may appear
What's normal
- •Abarelix is now achieving steady-state pharmacokinetics
- •Measurable changes aligned with Abarelix's mechanism may appear
- •Initial adjustment effects typically resolve by this point
What's next
- →Maintain Abarelix dosing exactly as established
- →Track progress toward intended outcomes in detail
- →Review lab work or biomarker changes with your healthcare team
Months 2-6
What you might notice
- •Sustained testosterone suppression maintained with monthly injections
- •Cancer progression slowed;
- •continuous hormonal control maintained
What's normal
- •Full therapeutic effects of Abarelix are well-characterized at this point
- •Maintenance of Abarelix's therapeutic effects is typical
- •Tolerance patterns with Abarelix are generally stable over months
What's next
- →Comprehensive assessment of Abarelix efficacy should be conducted
- →Discuss long-term continuation, cycling, or protocol modifications
- →Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Abarelix over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
Why was Abarelix withdrawn from the U.S. market?+
Praecis Pharmaceuticals voluntarily withdrew Plenaxis in June 2006, primarily due to limited market adoption and the availability of alternative GnRH therapies. Some reports cited rare but serious allergic reactions (anaphylaxis) in a small number of patients.
How is Abarelix different from GnRH agonists like leuprolide?+
Abarelix is a GnRH antagonist that blocks GnRH receptors immediately, preventing the initial testosterone surge (flare effect) seen with agonists. Agonists first stimulate GnRH receptors before causing feedback suppression, creating a temporary testosterone spike.
What is the advantage of no testosterone flare?+
The testosterone flare from agonists can temporarily worsen prostate cancer symptoms and increase pain. Abarelix avoids this by antagonizing GnRH directly, making it safer for patients with advanced disease.
Is Abarelix still available?+
In the United States, Abarelix is no longer available due to its 2006 withdrawal. However, it remains marketed in some countries including Germany and other European markets under the name Plenaxis.
What should I monitor while on Abarelix therapy?+
Regular monitoring should include testosterone levels, liver function tests, bone density (DXA scans), PSA levels, and clinical symptoms. Injection sites should be inspected for reactions. Any signs of allergic reaction (rash, difficulty breathing, swelling) require immediate medical attention.
08 · Further reading
History & related research
History · since 2003
The pioneer that opened a door, then closed it again
Abarelix was the first GnRH antagonist approved by the FDA, beating newer drugs to the market. It worked well to stop cancer, but it caused severe allergic reactions in some patients.
Read the full history of Abarelix